Scientists have tapped AI and powerful computing to speed up how quickly officials are able to learn important details about nuclear events.

Armed with some of the world’s most advanced instrumentation, researchers at PNNL are working to analyze huge amounts of data and uncover hidden biological connections.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

Glenn Fugate was selected to serve on the American Chemical Society's Science Committee.

Brian Milbrath, a physicist at Pacific Northwest National Laboratory (PNNL), was selected as a new Task Leader for the PrepCom’s Working Group B.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

New PNNL research makes it easier to differentiate between chemical and nuclear explosions.

The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

Rey Suarez is a nuclear nonproliferation researcher who is working on equipment that can detect radionuclides emitted from a nuclear explosion as part of treaty monitoring.

A paper by PNNL scientists on nuclear explosion monitoring technology is among top articles in nuclear instruments journal to draw most social media “buzz.”

Scientists at PNNL have contributed much of the nuclear science that underlies an international monitoring system designed to detect nuclear explosions worldwide. The system detects radioxenon anywhere on the planet.

PNNL wins seven R&D 100 awards – total tops 100